It has also been shown that among Alzheimer’s disease patients, those who were homozygous for APOE-ε4 had shorter LTL than those who were heterozygous for APOE-ε4 or noncarriers (32). This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.